Global Med Technologies Announces Acquisition of eDonor(R): One of the Industry's Premier Technology Platforms for Donor Recruit
August 01 2008 - 9:00AM
PR Newswire (US)
- Accretive U.S. 'Tuck-in' Purchase Adds Fully Integrated Web-Based
Donor Recruitment System to Suite of Products DENVER, Aug. 1
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
today announced that it has executed an Asset Purchase Agreement
and closed a transaction with eDonor, located in Phoenix, Arizona,
for $5 million. This acquisition is expected to be accretive
immediately on a fully diluted basis, net of financing costs. The
transaction consists of $3.5 million in cash and $1.5 million in
Global Med common stock. eDonor is a web-based donor relationship
management system that integrates recruitment, scheduling,
retention and fulfillment for national as well as local community
blood centers. The acquisition is designed to complement Global
Med's strong line of international blood management and laboratory
information software and service solutions. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Dr.
Mick Ruxin, Chairman and CEO of Global Med Technologies, Inc.,
commented, "Global Med's vision is to provide comprehensive
solutions for the blood management software industry. We realize
that effective donor recruitment is strategically important to our
customers. eDonor's significant market share and their innovative
solutions make this acquisition a logical next step in our
evolution. We feel strongly that eDonor will benefit both existing
and new blood bank customers of Global Med's Wyndgate
Technologies(R) division and Global Med's recent international
acquisition of Inlog, SA." Dr. Ruxin continued, "With the eDonor
acquisition, Global Med will now have 13 software applications
specifically geared toward donor centers and hospitals." The eDonor
application has evolved to become the donor industry's premier
technology platform for donor recruitment, scheduling and
retention. Community blood centers view recruitment and retention
of quality donor pools as a priority to meet local transfusion
needs. Among eDonor's notable U.S. clients are the American Red
Cross, Blood Systems, Inc. (BSI) Blood Centers/Testing Facilities,
the Institute for Transfusion Medicine, Florida's Blood Centers,
Lockheed/Armed Services Blood Program, and the Blood and Tissue
Center of Central Texas. Global Med's European software subsidiary,
Inlog, SA, will be a key driver to introducing eDonor's effective
donor relationship management system internationally. Thomas F.
Marcinek, President and COO of Global Med Technologies, Inc.,
stated, "Acquiring a proven, profitable and well-established market
leader in donor recruitment reduces the risk of product development
and accelerates our time to market. With eDonor, we can now deliver
a turn-key, fully integrated suite of products that eliminates the
complexity and risk of integration while lowering the total cost of
ownership. We have great respect for the management team of eDonor
and their many accomplishments and look forward to our combined
synergies. This is truly a win-win for Global Med, eDonor, our
employees, our combined customer base and the industry." The
primary components of eDonor's product line unite flexible list
management tools with multiple communication channels to increase
donor retention and donation frequency. In addition, eDonor can
automate manual recruitment and scheduling processes that improve
productivity and lower costs. eDonor also supports the development
and deployment of sophisticated donor loyalty programs which
further enhance a blood center's relationship with its donors.
eDonor's audited revenues for 2007 were $3.3 million and their net
profit was $337,000. For more information about eDonor and its
products visit http://www.edonor.com/. Michael N. Pandelakis,
President and CEO of eDonor, commented, "We have always admired
Global Med -- not only for their success in the marketplace, but
also for their consistently solid reputation with their customers.
While the product and services fit was obvious and the synergies
readily apparent, it was the cultural fit that we believe will
ensure a quick and seamless integration. We feel honored to join
this winning team and contribute our efforts to serving our joint
customer base." About Global Med Technologies, Inc. Global Med
Technologies(R), Inc. is an international medical software company
which develops regulated and non-regulated software products and
services for the healthcare industry. As a leading provider of
blood and laboratory software applications and services, Global
Med's products are deployed in 20 countries and serve over 1,400
transfusion centers, blood banks and laboratories. Global Med's
U.S. division, Wyndgate Technologies(R), provides Vein-to-Vein(R)
tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R)
and ElDorado Donor(TM) software products. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply. Global
Med's European subsidiary, Inlog, SA, is a leading provider of
donor center and transfusion management systems as well as cellular
therapy software, laboratory information systems and quality
assurance medical software systems internationally. Inlog's
products include EdgeBlood**, EdgeTrack**, EdgeCell, EdgeLab and
SAPA. Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides
cost-effective customized software validation, consulting and
compliance solutions to hospitals and donor centers. For more
information about Global Med's products and services, please call
800-996-3428 or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/, http://www.inlog.com/ and
http://www.wyndgate.com/. **FDA 510(k) clearance required prior to
sales in the U.S. This news release may include statements that
constitute forward-looking statements, usually containing the words
"believe," "estimate," "project," "expects" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: Company, Michael I. Ruxin, M.D. of Global Med
Technologies(R), Inc., +1-303-238-2000, ; or Investors, Paul Holm,
President of portfoliopr, +1-212-999-5585, , for Global Med
Technologies, Inc. Web site: http://www.globalmedtech.com/
http://www.peoplemed.com/ http://www.inlog.com/
http://www.wyndgate.com/
Copyright